Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases?
Is there a role for CDK 4/6 inhibitors in breast cancer brain metastases? |
|
https://doi.org/10.18632/oncotarget.27904
Ilana Schlam,
and Sara M. Tolaney
|
| 873-875 |
Epigenetic effects of pharmacologic ascorbate
Epigenetic effects of pharmacologic ascorbate |
|
https://doi.org/10.18632/oncotarget.27911
Garett J. Steers,
Rory S. Carroll,
Brianne R. O’Leary,
and Joseph J. Cullen
|
| 876-877 |
Activation of plasmacytoid dendritic cells promotes AML-cell fratricide
Activation of plasmacytoid dendritic cells promotes AML-cell fratricide |
|
https://doi.org/10.18632/oncotarget.27949
Kavin Fatehchand,
Payal Mehta,
Christopher B. Colvin,
Nathaniel J. Buteyn,
Ramasamy Santhanam,
Giovanna Merchand-Reyes,
Hafza Inshaar,
Brenda Shen,
Xiaokui Mo,
Bethany Mundy-Bosse,
Susheela Tridandapani,
and Jonathan P. Butchar
|
| 878-890 |
Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore
Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore |
|
https://doi.org/10.18632/oncotarget.27933
Sateja Paradkar,
James Herrington,
Adam Hendricson,
Piyasena Hewawasam,
Mark Plummer,
Denton Hoyer,
Ranjini K. Sundaram,
Yulia V. Surovtseva,
and Ranjit S. Bindra
|
| 891-906 |
Piperlongumine promotes death of retinoblastoma cancer cells
Piperlongumine promotes death of retinoblastoma cancer cells |
|
https://doi.org/10.18632/oncotarget.27947
Nathalie Allaman-Pillet,
and Daniel F. Schorderet
|
| 907-916 |
A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer
A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer |
|
https://doi.org/10.18632/oncotarget.27944
Sachi Fukui-Kawaura,
Takashi Kawahara,
Yushi Araki,
Reona Nishimura,
Koichi Uemura,
Kazuhiro Namura,
Nobuhiko Mizuno,
Masahiro Yao,
Hiroji Uemura,
and Ichiro Ikeda
|
| 917-922 |
Down regulation of lactate dehydrogenase initiates apoptosis in HeLa and MCF-7 cancer cells through increased voltage-dependent anion channel protein and inhibition of BCL2
Down regulation of lactate dehydrogenase initiates apoptosis in HeLa and MCF-7 cancer cells through increased voltage-dependent anion channel protein and inhibition of BCL2 |
|
https://doi.org/10.18632/oncotarget.27950
Suhail Al-Salam,
Karthishwaran Kandhan,
and Manjusha Sudhadevi
|
| 923-935 |
Multigene tests for breast cancer: the physician’s perspective
Multigene tests for breast cancer: the physician’s perspective |
|
https://doi.org/10.18632/oncotarget.27948
Francesco Cognetti,
Laura Biganzoli,
Sabino De Placido,
Lucia del Mastro,
Riccardo Masetti,
Giuseppe Naso,
Giancarlo Pruneri,
Donatella Santini,
Carlo Alberto Tondini,
Corrado Tinterri,
Giuseppe Tonini,
and Sandro Barni
|
| 936-947 |
Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma |
|
https://doi.org/10.18632/oncotarget.27444
Prahlad V. Raninga,
Giovanna Di Trapani,
Slavica Vuckovic,
Maneet Bhatia,
and Kathryn F. Tonissen
|
| 948-949 |
